FDA issued a Warning Letter to Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy on 7/30/2018 for a previous inspection.
483 Kelley-Ross & Associates dba Kelley-Ross Compounding P Sep 2020

483 Kelley-Ross & Associates dba Kelley-Ross Compounding P Sep 2020

Christopher Czajka FDA$119.00 - Available Now

FDA investigators audited the Kelley-Ross & Associates dba Kelley-Ross Compounding P - Seattle, WA, United States facility and issued inspectional observations (via FDA 483) on 23 Sep 2020.

Product details

  • Category: Human Drugs
  • Inspection end: 23 Sep 2020
  • Location: Seattle, United States
  • FEI: 3013436443
Add To Cart